Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program

被引：27
|
作者：
de Gramont, Aimery [1 ]
Haller, Daniel G. [2 ]
Sargent, Daniel J. [3 ]
Tabernero, Josep [4 ]
Matheson, Alastair [5 ]
Schilsky, Richard L. [6 ]
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Mayo Clin, Canc Ctr Stat, Rochester, MN USA
[4] Vall Hebron Univ Hosp, Med Oncol Serv, Barcelona, Spain
[5] Fdn ARCAD, Paris, France
[6] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 04期
关键词：
FLUOROURACIL PLUS LEUCOVORIN; PROGRESSION-FREE SURVIVAL; INDIVIDUAL PATIENT DATA; END-POINTS; 1ST-LINE TREATMENT; ORAL CAPECITABINE; CRITICAL PATH; COLON-CANCER; IRINOTECAN; DRUG;
D O I：
10.1200/JCO.2009.25.2544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：527 / 530
页数：4
相关论文
共 50 条
  • [21] Public attitudes toward participation in cancer clinical trials
    Comis, RL
    Miller, JD
    Aldigé, CR
    Krebs, L
    Stoval, E
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 830 - 835
  • [22] Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)
    Basulaiman, Bassam
    Awan, Arif Ali
    Fergusson, Dean
    Vandermeer, Lisa
    Arnaout, Angel
    Hilton, John
    Hutton, Brian
    Joy, Anil Abraham
    Robinson, Andrew
    Califaretti, Nadia
    Stober, Carol
    Sienkiewicz, Marta
    Thavorn, Kednapa
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (01) : 93 - 101
  • [23] Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)
    Bassam Basulaiman
    Arif Ali Awan
    Dean Fergusson
    Lisa Vandermeer
    Angel Arnaout
    John Hilton
    Brian Hutton
    Anil Abraham Joy
    Andrew Robinson
    Nadia Califaretti
    Carol Stober
    Marta Sienkiewicz
    Kednapa Thavorn
    Mark Clemons
    Breast Cancer Research and Treatment, 2019, 177 : 93 - 101
  • [24] Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database
    Renfro, Lindsay A.
    Loupakis, Fotios
    Adams, Richard A.
    Seymour, Matthew T.
    Heinemann, Volker
    Schmoll, Hans-Joachim
    Douillard, Jean-Yves
    Hurwitz, Herbert
    Fuchs, Charles S.
    Diaz-Rubio, Eduardo
    Porschen, Rainer
    Tournigand, Christophe
    Chibaudel, Benoist
    Falcone, Alfredo
    Tebbutt, Niall C.
    Punt, Cornelis J. A.
    Hecht, J. Randolph
    Bokemeyer, Carsten
    Van Cutsem, Eric
    Goldberg, Richard M.
    Saltz, Leonard B.
    de Gramont, Aimery
    Sargent, Daniel J.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) : 144 - +
  • [25] Toward a model of clinical trials
    Ali, LC
    Fazi, P
    Luzi, D
    Ricci, FL
    Serbanati, LD
    Vignetti, M
    BIOLOGICAL AND MEDICAL DATA ANALYSIS, PROCEEDINGS, 2004, 3337 : 299 - 312
  • [26] A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group
    Bleiberg, H.
    Decoster, G.
    de Gramont, A.
    Rougier, P.
    Sobrero, A.
    Benson, A.
    Chibaudel, B.
    Douillard, J. Y.
    Eng, C.
    Fuchs, C.
    Fujii, M.
    Labianca, R.
    Larsen, A. K.
    Mitchell, E.
    Schmoll, H. J.
    Sprumont, D.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 922 - 930
  • [27] Clinical trials versus clinical practice in colorectal cancer: Equivalent populations?
    Cremades, Alejandra Magdaleno
    Castaño, Maria del Carmen Ors
    Espinosa, Maria Ballester
    Cuquerella, Marta Llopis
    Belloch, Maria del Rocio Ramirez
    Aracil, Vicente Boix
    Gomez Gonzalez, Lucia
    Morales Gimenez, Roberto
    Asensio Martinez, Elena
    Gallego Plazas, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [28] Murine clinical trials program
    Brockenbrough, J. Scott
    Feng, Libing
    Stromnes, Ingunn M.
    DelGiorno, Kathleen E.
    Whittle, Martin C.
    Cuevas, Carlos
    Dotson, Ashley M.
    Ryan, Joseph S.
    Thorsen, Shelley M.
    Hingorani, Sunil R.
    CANCER RESEARCH, 2015, 75
  • [29] Tumor bulk as a prognostic biomarker and predictor of benefit from anti-EGFR therapy in patients with metastatic colorectal cancer: Analysis of 476 patients from the ARCAD Clinical Trials Program.
    Weinberg, Benjamin Adam
    Rakez, Manel
    Chibaudel, Benoist
    Maughan, Tim
    Adams, Richard
    Zalcberg, John Raymond
    Grothey, Axel
    Yoshino, Takayuki
    Shi, Qian
    De Gramont, Aimery
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [30] Recent Clinical Trials in Relapsed/Refractory Metastatic Colorectal Cancer
    Marshall, John L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 3 - 7
12345